Sulforaphane Clinical analysis

Sulforaphane Dosage: Human Trial Doses, µmol to mg & Myrosinase

Sulforaphane dosage explained without label confusion: human trial doses, µmol-to-mg conversion, glucoraphanin vs sulforaphane, myrosinase, bioavailability and safety.

Published
Last reviewed
Reading time
13 min
Sources cited
14
DoNotAge SulforaBoost beside water and a notebook.
On this page

There is no single established sulforaphane dosage that applies to everyone—and the biggest source of confusion is that “dose” can describe completely different things.

A label might report grams of broccoli, milligrams of broccoli extract, micromoles of glucoraphanin, milligrams of a combined glucoraphanin/myrosinase formula, or milligrams of sulforaphane itself. Those numbers cannot be compared as if they were the same unit of exposure.

The rule: identify what the number measures before deciding whether a dose is low, high or comparable with a clinical trial.

The four dose languages you need to separate

Dose language What it tells you What it does not tell you
Food or extract weight How much broccoli, sprout powder or extract was administered The amount of glucoraphanin, myrosinase activity or sulforaphane delivered
Glucoraphanin dose How much sulforaphane precursor was administered How efficiently it will convert without knowing myrosinase and formulation
Nominal sulforaphane dose The amount of sulforaphane itself or a defined sulforaphane-equivalent exposure The exact systemic exposure in every person
Internal exposure Plasma/urinary sulforaphane metabolites after absorption A guaranteed clinical benefit

Human sulforaphane doses used in clinical studies

Study context Administered exposure Duration What happened
Phase I sprout-extract safety 25 or 100 µmol glucosinolates, or 25 µmol isothiocyanates, every 8 hours 7 days No significant or consistent toxicity attributed to the tested preparations.[1]
Autism, 2014 50–150 µmol/day broccoli-sprout-derived sulforaphane 18 weeks Several behavioral scales improved versus placebo.[2]
Type 2 diabetes, 2017 150 µmol/day 12 weeks Strongest glycemic signal in obese participants with dysregulated diabetes.[3]
COPD 25 or 150 µmol/day 4 weeks No significant prespecified NRF2-target or clinical benefit.[4]
Recurrent prostate cancer 200 µmol/day Up to 20 weeks Primary PSA-response endpoint not met.[5]
Former smokers at high lung-cancer risk Potential daily dose about 95 µmol/day 12 months Ki-67 fell; histopathology and apoptosis endpoints did not significantly improve.[6]
Stabilized sulforaphane Phase I 46.2 mg/day; 46.2 mg twice daily; or 92.4 mg/day of sulforaphane via SFX-01 7 days Predictable absorption; gastrointestinal adverse events were common but mostly mild and transient.[7]

µmol to mg: how to convert pure sulforaphane

Clinical research often reports sulforaphane in micromoles (µmol). Using a molecular weight of about 177.29 g/mol, 1 µmol of pure sulforaphane is approximately 0.177 mg.

Pure sulforaphane Approximate mass
25 µmol 4.4 mg
50 µmol 8.9 mg
100 µmol 17.7 mg
150 µmol 26.6 mg
200 µmol 35.5 mg

Do not apply this conversion to broccoli-extract or glucoraphanin weight. One hundred milligrams of glucoraphanin is not 17.7 mg of sulforaphane, and 500 mg of broccoli extract is not 500 mg of sulforaphane.

DoNotAge SulforaBoost front-label detail.

Why the administered dose can be nothing like the delivered dose

Cooking can change exposure by an order of magnitude

Eight men consumed the same 200 g amount of broccoli raw or cooked. Estimated sulforaphane bioavailability was about 37% after raw broccoli and 3.4% after cooked broccoli, with much faster peak exposure after the raw preparation.[8]

Same broccoli weight. Very different internal dose.

Myrosinase changes precursor conversion

A 2026 crossover study found average sulforaphane bioavailability of 39.8% when mustard-seed myrosinase was added to a glucoraphanin-rich extract versus 18.6% without the added enzyme.[9]

Another crossover feeding study showed that adding 1 g of brown mustard powder to cooked broccoli increased urinary sulforaphane-N-acetylcysteine more than fourfold.[10]

A supplement can contain precursor and still deliver little sulforaphane

Fresh broccoli sprouts produced substantially higher and earlier plasma and urinary sulforaphane-metabolite exposure than a tested broccoli supplement whose myrosinase had been inactivated.[11]

This is why “broccoli supplement 500 mg” is not a clinically useful dose description by itself.

Stomach conditions and delivery design can matter too

A human pilot using glucoraphanin-rich broccoli seed/sprout extract with active myrosinase found that conversion varied with omeprazole treatment and enteric coating.[12] The practical point is not that everyone should take a proton-pump inhibitor—far from it. It is that active myrosinase can still be affected by how and where a formulation releases.

Is there an official recommended daily allowance?

No. There is no established Recommended Dietary Allowance, universal optimal daily dose or validated long-term tolerable upper intake level for sulforaphane supplements.

Human studies provide studied exposures, not a single dose prescription for healthy consumers. Disease trials often choose doses for a specific mechanistic or clinical question and should not be treated as everyday wellness recommendations.

Does taking more sulforaphane work better?

Not reliably. A pollution-biomarker trial found a dose-response pattern for one benzene-related endpoint, with the full tested beverage concentration producing the clearest effect.[13] But the COPD trial included a 150 µmol/day arm and remained negative for its prespecified airway NRF2 and clinical endpoints.[4]

At much higher direct sulforaphane exposure, the SFX-01 Phase I trial also shows that tolerability becomes part of the dose question. Seventeen of 18 active-treatment participants reported treatment-emergent adverse events, most commonly gastrointestinal symptoms, although most were mild and transient.[7]

More exposure is not automatically more benefit.

Broccoli florets, mustard seeds and sprouts in separate dishes.

Once daily or split dosing?

A small human feeding study compared once-daily with divided exposure and found that splitting the total daily intake helped sustain plasma sulforaphane metabolites later in the dosing interval.[14]

That is pharmacokinetically plausible, but the study did not show that split dosing improves clinical outcomes. For a commercial supplement, the tested product instructions are a more defensible starting point than inventing an optimization protocol from plasma curves.

How to evaluate the dose on a supplement label

  1. Identify the measured compound. Is the number broccoli extract, glucoraphanin, sulforaphane or combined formula weight?
  2. If it is glucoraphanin, look for active myrosinase.
  3. Do not infer sulforaphane from total extract weight.
  4. Be suspicious of cross-product dose comparisons that mix µmol, mg of precursor and mg of total blend.
  5. Match the trial to the formulation. A study of stabilized direct sulforaphane is not an equivalent-dose study of a glucoraphanin capsule.
  6. Use tolerability and clinical context, not the largest number, to judge whether a dose is sensible.

Bottom line

The question “How much sulforaphane per day?” has no defensible one-number answer. Human trials study exposures ranging from single-digit milligram-equivalents to pharmacologic direct-sulforaphane doses, but the effective internal dose depends on formulation.

First identify what the label is measuring. Then ask how glucoraphanin becomes sulforaphane, how the product handles myrosinase and delivery, and whether the trial being cited actually tested the same type of formulation. For the broader product framework, see our sulforaphane supplement guide; for safety, see sulforaphane side effects.

Frequently asked questions

How much sulforaphane should I take per day?

There is no universally established optimal daily sulforaphane dose. Human studies use different preparations and exposures, so a research dose must be interpreted together with formulation, myrosinase activity and the outcome being studied.

How do I convert sulforaphane from µmol to mg?

Using sulforaphane's molecular weight of about 177.29 g/mol, 1 µmol of pure sulforaphane is about 0.177 mg. Therefore 25 µmol ≈ 4.4 mg, 50 ≈ 8.9 mg, 100 ≈ 17.7 mg, 150 ≈ 26.6 mg and 200 ≈ 35.5 mg. This conversion is only for sulforaphane itself.

Is 500 mg of broccoli extract equal to 500 mg of sulforaphane?

No. Broccoli-extract weight includes many compounds and does not reveal how much glucoraphanin or sulforaphane is present, whether active myrosinase survives, or how much sulforaphane will be generated and absorbed.

Is a higher sulforaphane dose better?

Not necessarily. Some biomarker studies show dose-response patterns, while other trials remain negative at relatively high exposures. Higher direct sulforaphane doses can also increase gastrointestinal tolerability issues.

Should sulforaphane be taken once daily or split?

A small feeding study suggests split dosing can maintain plasma metabolites later in the dosing interval, but there is no evidence that split dosing produces better clinical outcomes. Use the tested product instructions unless a clinician recommends otherwise.

Share this article

Send the research to someone who would find it useful.

Facebook X LinkedIn Reddit WhatsApp Email

Sources & article history

Sources (14)
  1. Theresa A Shapiro, et al. Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study Nutrition and Cancer. 2006;55(1):53-62.
  2. Lauren L Atwell, et al. Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase-treated broccoli sprout extract Molecular Nutrition & Food Research. 2015;59(3):424-433.
  3. Angela Mastaloudis, et al. Exogenous myrosinase from mustard seed increases bioavailability of sulforaphane from a glucoraphanin-rich broccoli seed extract in a randomized clinical study Scientific Reports. 2026;16(1).
  4. Annika S Axelsson, et al. Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes Science Translational Medicine. 2017;9(394):eaah4477.
  5. Jian-Guo Chen, et al. Dose-dependent detoxication of the airborne pollutant benzene in a randomized trial of broccoli sprout beverage in Qidong, China The American Journal of Clinical Nutrition. 2019;110(3):675-684.
  6. Kanwaljit Singh, et al. Sulforaphane treatment of autism spectrum disorder (ASD) Proceedings of the National Academy of Sciences of the United States of America. 2014;111(43):15550-15555.
  7. Joshi J Alumkal, et al. A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer Investigational New Drugs. 2015;33(2):480-489.
  8. Robert A Wise, et al. Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial PLOS ONE. 2016;11(11):e0163716.
  9. Jian-Min Yuan, et al. Randomized Phase II Clinical Trial of Sulforaphane in Former Smokers at High Risk for Lung Cancer Cancer Prevention Research. 2025;18(6):335-345.
  10. Martijn Vermeulen, et al. Bioavailability and kinetics of sulforaphane in humans after consumption of cooked versus raw broccoli Journal of Agricultural and Food Chemistry. 2008;56(22):10505-10509.
  11. John D Clarke, et al. Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design Pharmacological Research. 2011;64(5):456-463.
  12. Olukayode Okunade, et al. Supplementation of the Diet by Exogenous Myrosinase via Mustard Seeds to Increase the Bioavailability of Sulforaphane in Healthy Human Subjects after the Consumption of Cooked Broccoli Molecular Nutrition & Food Research. 2018;62(18):e1700980.
  13. Jed W Fahey, et al. Bioavailability of Sulforaphane Following Ingestion of Glucoraphanin-Rich Broccoli Sprout and Seed Extracts with Active Myrosinase: A Pilot Study of the Effects of Proton Pump Inhibitor Administration Nutrients. 2019;11(7):1489.
  14. Glen Clack, et al. A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants Advances in Therapy. 2025;42(1):216-232.